r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
Comparison · Analytics
pharmaverseadam vs S7
A side-by-side editorial comparison of pharmaverseadam and S7 — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:r-language
pharmaverseadam vs S7: at a glance
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
What is S7?
S7 has stopped adding surface and started proving it holds up against R itself.
S7 is R's third-generation object system, built to unify the S3 and S4 lineages rather than add a fourth. The design work landed in 0.2.0, which reworked the default constructor, extended base-class coverage, and added a backward-compatibility shim so `@` property access works on R older than 4.3. Everything since has been maintenance: property setters gained a `check` escape hatch, and two consecutive releases exist mainly to keep the package compiling against R-devel 4.6.
pharmaverseadam vs S7: editorial side-by-side
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
S7
0.0ANALYTICS
S7 has stopped adding surface and started proving it holds up against R itself.
◆ Current state
S7 is R's third-generation object system, built to unify the S3 and S4 lineages rather than add a fourth. The design work landed in 0.2.0, which reworked the default constructor, extended base-class coverage, and added a backward-compatibility shim so `@` property access works on R older than 4.3. Everything since has been maintenance: property setters gained a `check` escape hatch, and two consecutive releases exist mainly to keep the package compiling against R-devel 4.6.
◆ Where it's heading
The changelog is thinning by design — 0.1.0 was a months-long feature dump, 0.2.0 a coordinated architectural revision, 0.2.2 a single line about internal R-devel support. That shape usually means an API the maintainers consider settled, where the remaining work is tracking the host language rather than extending the system. The one recurring theme is validation cost: repeated releases have made validation less frequent, more targeted, or skippable outright.
◆ Prediction
Expect continued small releases pinned to R-devel changes rather than new class-system features, with any further movement most likely in the validation and property-setter path that the last two feature changes both touched.
Alternatives to pharmaverseadam and S7
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or S7.
DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul
crul took mocking back from webmockr and made it a property of the client itself
dendroNetwork
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all pharmaverseadam alternatives → · See all S7 alternatives →
Recent activity from pharmaverseadam and S7
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 3mo agoS7Internal fixes for R-devel 4.6 compatibility
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 9mo agoS7Property setters gain an opt-out from validation
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agoS7Constructor rework and pre-4.3 support for @ access ⚡
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
- 2y agoS7Per-property validators and better S3 method registration
- 2y agoS7First release: unions, set_props, and S4 virtual dispatch
Frequently asked questions
What is the difference between pharmaverseadam and S7?
Both compete on the same themes — r-language — within Analytics. pharmaverseadam and S7 are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is pharmaverseadam better than S7?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. pharmaverseadam and S7 are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.
What are the best alternatives to S7?
Top S7 alternatives in Analytics are ranked by recent ship velocity. Browse the "S7 alternatives" section above for the current picks, or visit /alternatives/s7 for the full list with editorial commentary on each.